Information for People With Diabetes
From the Diabetes and Glandular Disease Clinic Study,
San Antonio, Texas:
“This study did not detect any deleterious effect of 10 days of dosing with sugar-free Cold-EEZE® lozenges on diabetic control as assessed by fructosamine level, fasting blood glucose level and home glucose monitoring.”
A single-center, randomized, single-blind placebo-controlled trial was conducted in patients with diabetes to assess the effects of sugar-free Cold-EEZE tablets on glucose control in patients maintained on stable antidiabetic therapy.
Patients:
- 48 persons with Type 1 or Type 2 diabetes were treated with Cold-EEZE sugar-free zinc or placebo tablets for relief of cold symptoms.
- 13 persons received sugar-free placebo tablets.
- 35 persons received sugar-free Cold-EEZE tablets.
Measures:
Fasting blood glucose level was measured at baseline, study day 10 and study day 21
Results
No detrimental effect on overall diabetic control.
Adverse Events:
No patients withdrew from the trial. There were no serious adverse events.
About Cold-EEZE Sugar-Free Tablets:
- Each box contains 48 Zinc Gluconate Glycine (ZIGG™) tablets.
- Each tablet contains 4.3 mg of Ionic Zinc.
- Flavor: Chocolate Mint Flavor/Unsweetened.
- Recommended daily dose: One tablet per hour, maximum of 16 daily.
- Clinically proven to be safe for people with diabetes.
- Contains 0 carbohydrates, 0 calories.